PL4037679T3 - Sposób wytwarzania walsartanu o wysokiej czystości - Google Patents
Sposób wytwarzania walsartanu o wysokiej czystościInfo
- Publication number
- PL4037679T3 PL4037679T3 PL20896548.3T PL20896548T PL4037679T3 PL 4037679 T3 PL4037679 T3 PL 4037679T3 PL 20896548 T PL20896548 T PL 20896548T PL 4037679 T3 PL4037679 T3 PL 4037679T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- highly pure
- pure valsartan
- valsartan
- highly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921049418 | 2019-12-02 | ||
| PCT/IN2020/050990 WO2021111464A1 (en) | 2019-12-02 | 2020-11-28 | A process for the preparation of highly pure valsartan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4037679T3 true PL4037679T3 (pl) | 2026-03-09 |
Family
ID=76221532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20896548.3T PL4037679T3 (pl) | 2019-12-02 | 2020-11-28 | Sposób wytwarzania walsartanu o wysokiej czystości |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12365654B2 (pl) |
| EP (1) | EP4037679B1 (pl) |
| CN (1) | CN114845713B (pl) |
| ES (1) | ES3048170T3 (pl) |
| PL (1) | PL4037679T3 (pl) |
| WO (1) | WO2021111464A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4422615A4 (en) * | 2021-10-28 | 2025-09-17 | Texas A & M Univ Sys | COMPOSITIONS OF STABLE METFORMIN AND SIMILAR DRUG PRODUCTS WITH CONTROL OF NITROSO IMPURITIES |
| US20250269350A1 (en) * | 2022-04-22 | 2025-08-28 | Benjamin V. Mork | Compositions and methods for remediation using dithionite and activated carbons |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122007000050I1 (de) | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
| US5260325A (en) | 1991-08-19 | 1993-11-09 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking tertiary amides |
| US5488141A (en) * | 1994-06-10 | 1996-01-30 | Rohm And Haas Company | Removal of carbonyl impurities from αβ unsaturated carboxylic acid esters |
| AU1600297A (en) | 1996-02-15 | 1997-09-02 | Novartis Ag | Aryl derivatives |
| IT1292437B1 (it) | 1997-06-30 | 1999-02-08 | Zambon Spa | Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti |
| IT1301759B1 (it) | 1998-06-19 | 2000-07-07 | Nicox Sa | Sali nitrati di farmaci antiipertensivi |
| AU2001267404A1 (en) | 2000-05-04 | 2001-11-12 | Ipf Pharmaceuticals Gmbh | Novel compounds for the treatment of inflammatory and cardiovascular diseases |
| AR032758A1 (es) * | 2000-07-19 | 2003-11-26 | Novartis Ag | Sales valsartan, un proceso para su fabricacion, composiciones farmaceuticas y el uso de dichas sales para la preparacion de medicamentos |
| WO2009001375A2 (en) * | 2007-06-27 | 2008-12-31 | Matrix Laboratories Ltd | Improved process for preparing pure valsartan |
| US10077251B2 (en) * | 2012-10-29 | 2018-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of Dabigatran Etexilate and its intermediates |
| CN109641856B (zh) * | 2016-09-02 | 2022-09-30 | 南京诺瑞特医药科技有限公司 | 缬沙坦二钠盐的晶型 |
| WO2020010643A1 (zh) * | 2018-07-13 | 2020-01-16 | 浙江华海药业股份有限公司 | 一种缬沙坦的合成方法 |
| CN109761924B (zh) * | 2019-02-26 | 2020-09-01 | 安徽美诺华药物化学有限公司 | 一种改进的缬沙坦反应混合液的后处理方法 |
-
2020
- 2020-11-28 CN CN202080082890.9A patent/CN114845713B/zh active Active
- 2020-11-28 PL PL20896548.3T patent/PL4037679T3/pl unknown
- 2020-11-28 EP EP20896548.3A patent/EP4037679B1/en active Active
- 2020-11-28 ES ES20896548T patent/ES3048170T3/es active Active
- 2020-11-28 US US17/782,048 patent/US12365654B2/en active Active
- 2020-11-28 WO PCT/IN2020/050990 patent/WO2021111464A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4037679A1 (en) | 2022-08-10 |
| EP4037679A4 (en) | 2023-11-08 |
| CN114845713A (zh) | 2022-08-02 |
| EP4037679B1 (en) | 2025-08-06 |
| CN114845713B (zh) | 2025-07-08 |
| ES3048170T3 (en) | 2025-12-09 |
| WO2021111464A1 (en) | 2021-06-10 |
| US20230057675A1 (en) | 2023-02-23 |
| US12365654B2 (en) | 2025-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286566A (en) | A process for the preparation of microbiocidal derivatives of oxadiazole | |
| IL276917A (en) | A process for the preparation of alubixivet | |
| SG11202109780VA (en) | Process for the preparation of battery precursors | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| IL289904A (en) | A process for preparing biphenylamines | |
| IL268835B (en) | A process for the preparation of 2-cyanoimidazole compounds | |
| SG11202108238VA (en) | Process for the preparation of methionine | |
| HUE063118T2 (hu) | Eljárás N-alkil-nitrátoetilnitraminok elõállítására | |
| IL275381A (en) | A process for the preparation of Crisborole | |
| IL291221A (en) | Methods for the synthesis of wolbenzine | |
| SG11202011687RA (en) | Process for the preparation of cyclopropane compounds using diazo-com pounds | |
| IL285550A (en) | Process for preparing polyamides | |
| PL4037679T3 (pl) | Sposób wytwarzania walsartanu o wysokiej czystości | |
| IL281254A (en) | A process for the preparation of lanbatinib | |
| IL275480A (en) | A process for the preparation of pyrimidinyl-4-aminopyrazole compounds | |
| IL268456B (en) | A new process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes | |
| IL283633A (en) | A process for preparing a cyclic dinucleotide | |
| IL290181B2 (en) | Process for preparing fluonesulfone | |
| IL276557A (en) | A process for making metformin | |
| PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
| IL286054A (en) | A process for the preparation of a modified imidazoquinoline | |
| ZA202102159B (en) | Process for the preparation of a flavouring | |
| HUP1800278A2 (en) | Process for the preparation of boc-linagliptin | |
| PL4013502T3 (pl) | Sposób otrzymywania pochodnej pirymidyno-diazepiny | |
| AU2018297073A1 (en) | Process for the preparation of morphinane compounds |